HPR82 Assessment of Supporting Evidence and Postmarketing Requirements for Therapeutic Indications With Real-Time Oncology Drug Review, 2018-2023
Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.1151
https://www.valueinhealthjournal.com/article/S1098-3015(24)01266-X/fulltext
Section Title :
Section Order :
10560
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)01266-X&doi=10.1016/j.jval.2024.03.1151